Neurocrine Biosciences Stock Forecast
Neurocrine Biosciences stock price ended at $131.74 on Monday, after losing 2.17%.
(Updated on Apr 15, 2024)
The Neurocrine Biosciences stock price fell by -2.17% on the last day (Monday, 15th Apr 2024) from $134.66 to $131.74. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 4.17% from a day low at $131.52 to a day high of $137.00. The price has fallen in 7 of the last 10 days and is down by -6.82% for this period. Volume has increased on the last day by 186 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 755 thousand shares were bought and sold for approximately $99.52 million.
The stock is at the lower part of a wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $130.52 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Neurocrine Biosciences stock with a 90% probability to be traded between $130.73 and $144.03 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
NBIX Signals & Forecast
There are few to no technical positive signals at the moment. The Neurocrine Biosciences stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $136.82 and $137.52. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 21, 2024, and so far it has fallen -8.35%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Neurocrine Biosciences stock
Neurocrine Biosciences finds support from accumulated volume at $131.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $5.48 between high and low, or 4.17%. For the last week the stock has had daily average volatility of 2.66%.
Our recommended stop-loss: $126.38 (-4.07%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 16 days ago.)
Trading Expectations (NBIX) For The Upcoming Trading Day Of Tuesday 16th
For the upcoming trading day on Tuesday, 16th we expect Neurocrine Biosciences to open at $133.42, and during the day (based on 14 day Average True Range), to move between $127.86 and $135.62, which gives a possible trading interval of +/-$3.88 (+/-2.94%) up or down from last closing price. If Neurocrine Biosciences takes out the full calculated possible swing range there will be an estimated 5.89% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $131.30 (0.33%) than the resistance at $133.84 (1.59%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Neurocrine Biosciences stock A Buy?
Neurocrine Biosciences holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: -0.554 Hold/Accumulate Unchanged
Predicted Opening Price for Neurocrine Biosciences of Tuesday, April 16, 2024
| Fair opening price April 16, 2024 | Current price |
|---|---|
| $133.42 ( 1.28%) | $131.74 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NBIX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 138.90 | 5.43 % | |
| R2 | 136.81 | 3.85 % | ||
| R1 | 135.51 | 2.86 % | ||
| Current price: | 131.74 | |||
| Support | S1 | 131.33 | -0.314 % | |
| S2 | 130.03 | -1.30 % | ||
| S3 | 127.94 | -2.88 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 143.74 | 9.11 % | |
| R2 | 136.29 | 3.45 % | ||
| R1 | 133.84 | 1.59 % | ||
| Current price | 131.74 | |||
| Support | S1 | 131.30 | -0.334% | |
| S2 | 130.43 | -0.99% | ||
| S3 | 130.40 | -1.02% |
FAQ
Click here for our free guide on how to buy Neurocrine Biosciences Stock.
